Guerbet SA
Guerbet SA GBT.PA Peers
See (GBT.PA) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| GBT.PA | $20.85 | -1.65% | 262.78M | 19.49 | $1.07 | +2.36% |
| PHIA.AS | $21.65 | -1.46% | 20.03B | 83.27 | $0.26 | N/A |
| IBAB.BR | $11.58 | +0.17% | 339.24M | 42.89 | $0.27 | +1.03% |
| EAPI.PA | $2.74 | -0.72% | 260.93M | -1.99 | -$1.38 | N/A |
| ALERS.PA | $25.30 | +0.32% | 253.14M | 64.87 | $0.39 | N/A |
| ALCOR.PA | $35.10 | +0.29% | 154.53M | -234.00 | -$0.15 | N/A |
| SEQUA.BR | $1.03 | -5.00% | 54.82M | -1.13 | -$0.91 | N/A |
| AFME.PA | $1.31 | -1.88% | 51.16M | -3.43 | -$0.38 | N/A |
| ALCAR.PA | $0.84 | +5.12% | 49.41M | -0.73 | -$1.15 | N/A |
| ALMDT.PA | $2.58 | +14.08% | 49.29M | -1.89 | -$1.37 | N/A |
Stock Comparison
GBT.PA vs PHIA.AS Comparison
GBT.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBT.PA stands at 262.78M. In comparison, PHIA.AS has a market cap of 20.03B. Regarding current trading prices, GBT.PA is priced at $20.85, while PHIA.AS trades at $21.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBT.PA currently has a P/E ratio of 19.49, whereas PHIA.AS's P/E ratio is 83.27. In terms of profitability, GBT.PA's ROE is +0.04%, compared to PHIA.AS's ROE of -0.06%. Regarding short-term risk, GBT.PA is more volatile compared to PHIA.AS. This indicates potentially higher risk in terms of short-term price fluctuations for GBT.PA.
GBT.PA vs IBAB.BR Comparison
GBT.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBT.PA stands at 262.78M. In comparison, IBAB.BR has a market cap of 339.24M. Regarding current trading prices, GBT.PA is priced at $20.85, while IBAB.BR trades at $11.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBT.PA currently has a P/E ratio of 19.49, whereas IBAB.BR's P/E ratio is 42.89. In terms of profitability, GBT.PA's ROE is +0.04%, compared to IBAB.BR's ROE of +0.09%. Regarding short-term risk, GBT.PA is more volatile compared to IBAB.BR. This indicates potentially higher risk in terms of short-term price fluctuations for GBT.PA.
GBT.PA vs EAPI.PA Comparison
GBT.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBT.PA stands at 262.78M. In comparison, EAPI.PA has a market cap of 260.93M. Regarding current trading prices, GBT.PA is priced at $20.85, while EAPI.PA trades at $2.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBT.PA currently has a P/E ratio of 19.49, whereas EAPI.PA's P/E ratio is -1.99. In terms of profitability, GBT.PA's ROE is +0.04%, compared to EAPI.PA's ROE of -0.14%. Regarding short-term risk, GBT.PA is more volatile compared to EAPI.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GBT.PA.
GBT.PA vs ALERS.PA Comparison
GBT.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBT.PA stands at 262.78M. In comparison, ALERS.PA has a market cap of 253.14M. Regarding current trading prices, GBT.PA is priced at $20.85, while ALERS.PA trades at $25.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBT.PA currently has a P/E ratio of 19.49, whereas ALERS.PA's P/E ratio is 64.87. In terms of profitability, GBT.PA's ROE is +0.04%, compared to ALERS.PA's ROE of +0.02%. Regarding short-term risk, GBT.PA is more volatile compared to ALERS.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GBT.PA.
GBT.PA vs ALCOR.PA Comparison
GBT.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBT.PA stands at 262.78M. In comparison, ALCOR.PA has a market cap of 154.53M. Regarding current trading prices, GBT.PA is priced at $20.85, while ALCOR.PA trades at $35.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBT.PA currently has a P/E ratio of 19.49, whereas ALCOR.PA's P/E ratio is -234.00. In terms of profitability, GBT.PA's ROE is +0.04%, compared to ALCOR.PA's ROE of -0.23%. Regarding short-term risk, GBT.PA is more volatile compared to ALCOR.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GBT.PA.
GBT.PA vs SEQUA.BR Comparison
GBT.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBT.PA stands at 262.78M. In comparison, SEQUA.BR has a market cap of 54.82M. Regarding current trading prices, GBT.PA is priced at $20.85, while SEQUA.BR trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBT.PA currently has a P/E ratio of 19.49, whereas SEQUA.BR's P/E ratio is -1.13. In terms of profitability, GBT.PA's ROE is +0.04%, compared to SEQUA.BR's ROE of +2.05%. Regarding short-term risk, GBT.PA is more volatile compared to SEQUA.BR. This indicates potentially higher risk in terms of short-term price fluctuations for GBT.PA.
GBT.PA vs AFME.PA Comparison
GBT.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBT.PA stands at 262.78M. In comparison, AFME.PA has a market cap of 51.16M. Regarding current trading prices, GBT.PA is priced at $20.85, while AFME.PA trades at $1.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBT.PA currently has a P/E ratio of 19.49, whereas AFME.PA's P/E ratio is -3.43. In terms of profitability, GBT.PA's ROE is +0.04%, compared to AFME.PA's ROE of -0.51%. Regarding short-term risk, GBT.PA is more volatile compared to AFME.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GBT.PA.
GBT.PA vs ALCAR.PA Comparison
GBT.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBT.PA stands at 262.78M. In comparison, ALCAR.PA has a market cap of 49.41M. Regarding current trading prices, GBT.PA is priced at $20.85, while ALCAR.PA trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBT.PA currently has a P/E ratio of 19.49, whereas ALCAR.PA's P/E ratio is -0.73. In terms of profitability, GBT.PA's ROE is +0.04%, compared to ALCAR.PA's ROE of +1.40%. Regarding short-term risk, GBT.PA is more volatile compared to ALCAR.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GBT.PA.
GBT.PA vs ALMDT.PA Comparison
GBT.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBT.PA stands at 262.78M. In comparison, ALMDT.PA has a market cap of 49.29M. Regarding current trading prices, GBT.PA is priced at $20.85, while ALMDT.PA trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBT.PA currently has a P/E ratio of 19.49, whereas ALMDT.PA's P/E ratio is -1.89. In terms of profitability, GBT.PA's ROE is +0.04%, compared to ALMDT.PA's ROE of +0.90%. Regarding short-term risk, GBT.PA is less volatile compared to ALMDT.PA. This indicates potentially lower risk in terms of short-term price fluctuations for GBT.PA.
GBT.PA vs ALNOV.PA Comparison
GBT.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBT.PA stands at 262.78M. In comparison, ALNOV.PA has a market cap of 33.36M. Regarding current trading prices, GBT.PA is priced at $20.85, while ALNOV.PA trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBT.PA currently has a P/E ratio of 19.49, whereas ALNOV.PA's P/E ratio is -0.77. In terms of profitability, GBT.PA's ROE is +0.04%, compared to ALNOV.PA's ROE of -0.23%. Regarding short-term risk, GBT.PA is less volatile compared to ALNOV.PA. This indicates potentially lower risk in terms of short-term price fluctuations for GBT.PA.
GBT.PA vs MKEA.PA Comparison
GBT.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBT.PA stands at 262.78M. In comparison, MKEA.PA has a market cap of 30.17M. Regarding current trading prices, GBT.PA is priced at $20.85, while MKEA.PA trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBT.PA currently has a P/E ratio of 19.49, whereas MKEA.PA's P/E ratio is -2.49. In terms of profitability, GBT.PA's ROE is +0.04%, compared to MKEA.PA's ROE of +0.74%. Regarding short-term risk, GBT.PA is more volatile compared to MKEA.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GBT.PA.
GBT.PA vs ALIKO.PA Comparison
GBT.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBT.PA stands at 262.78M. In comparison, ALIKO.PA has a market cap of 22.35M. Regarding current trading prices, GBT.PA is priced at $20.85, while ALIKO.PA trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBT.PA currently has a P/E ratio of 19.49, whereas ALIKO.PA's P/E ratio is -6.15. In terms of profitability, GBT.PA's ROE is +0.04%, compared to ALIKO.PA's ROE of -0.17%. Regarding short-term risk, GBT.PA is more volatile compared to ALIKO.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GBT.PA.
GBT.PA vs ALDMS.PA Comparison
GBT.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBT.PA stands at 262.78M. In comparison, ALDMS.PA has a market cap of 18.51M. Regarding current trading prices, GBT.PA is priced at $20.85, while ALDMS.PA trades at $1.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBT.PA currently has a P/E ratio of 19.49, whereas ALDMS.PA's P/E ratio is -8.24. In terms of profitability, GBT.PA's ROE is +0.04%, compared to ALDMS.PA's ROE of -0.25%. Regarding short-term risk, GBT.PA is more volatile compared to ALDMS.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GBT.PA.
GBT.PA vs ALTER.PA Comparison
GBT.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBT.PA stands at 262.78M. In comparison, ALTER.PA has a market cap of 17.29M. Regarding current trading prices, GBT.PA is priced at $20.85, while ALTER.PA trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBT.PA currently has a P/E ratio of 19.49, whereas ALTER.PA's P/E ratio is 42.00. In terms of profitability, GBT.PA's ROE is +0.04%, compared to ALTER.PA's ROE of -0.06%. Regarding short-term risk, GBT.PA is less volatile compared to ALTER.PA. This indicates potentially lower risk in terms of short-term price fluctuations for GBT.PA.
GBT.PA vs ALTHE.PA Comparison
GBT.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBT.PA stands at 262.78M. In comparison, ALTHE.PA has a market cap of 13.62M. Regarding current trading prices, GBT.PA is priced at $20.85, while ALTHE.PA trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBT.PA currently has a P/E ratio of 19.49, whereas ALTHE.PA's P/E ratio is -2.26. In terms of profitability, GBT.PA's ROE is +0.04%, compared to ALTHE.PA's ROE of -1.29%. Regarding short-term risk, GBT.PA is less volatile compared to ALTHE.PA. This indicates potentially lower risk in terms of short-term price fluctuations for GBT.PA.
GBT.PA vs ALIMP.PA Comparison
GBT.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBT.PA stands at 262.78M. In comparison, ALIMP.PA has a market cap of 12.62M. Regarding current trading prices, GBT.PA is priced at $20.85, while ALIMP.PA trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBT.PA currently has a P/E ratio of 19.49, whereas ALIMP.PA's P/E ratio is -2.52. In terms of profitability, GBT.PA's ROE is +0.04%, compared to ALIMP.PA's ROE of -2.06%. Regarding short-term risk, GBT.PA is more volatile compared to ALIMP.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GBT.PA.
GBT.PA vs ALEMG.PA Comparison
GBT.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBT.PA stands at 262.78M. In comparison, ALEMG.PA has a market cap of 11.29M. Regarding current trading prices, GBT.PA is priced at $20.85, while ALEMG.PA trades at $3.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBT.PA currently has a P/E ratio of 19.49, whereas ALEMG.PA's P/E ratio is 26.47. In terms of profitability, GBT.PA's ROE is +0.04%, compared to ALEMG.PA's ROE of +0.81%. Regarding short-term risk, GBT.PA is more volatile compared to ALEMG.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GBT.PA.
GBT.PA vs ALBLU.PA Comparison
GBT.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBT.PA stands at 262.78M. In comparison, ALBLU.PA has a market cap of 7.49M. Regarding current trading prices, GBT.PA is priced at $20.85, while ALBLU.PA trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBT.PA currently has a P/E ratio of 19.49, whereas ALBLU.PA's P/E ratio is -6.10. In terms of profitability, GBT.PA's ROE is +0.04%, compared to ALBLU.PA's ROE of -0.61%. Regarding short-term risk, GBT.PA is less volatile compared to ALBLU.PA. This indicates potentially lower risk in terms of short-term price fluctuations for GBT.PA.
GBT.PA vs ALSGD.PA Comparison
GBT.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GBT.PA stands at 262.78M. In comparison, ALSGD.PA has a market cap of 6.57M. Regarding current trading prices, GBT.PA is priced at $20.85, while ALSGD.PA trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GBT.PA currently has a P/E ratio of 19.49, whereas ALSGD.PA's P/E ratio is -1.17. In terms of profitability, GBT.PA's ROE is +0.04%, compared to ALSGD.PA's ROE of -0.59%. Regarding short-term risk, GBT.PA is more volatile compared to ALSGD.PA. This indicates potentially higher risk in terms of short-term price fluctuations for GBT.PA.